 AMARILLO, TX ACCESSWIRE April 21, 2021 Ainos, Inc., fka Amarillo Biosciences, Inc. we or the Company, OTCBB:AMAR, a company engaged in the discovery and development of pharmaceutical and biotech products, announced today that it has consummated the transaction pursuant to that certain Securities Purchase Agreement Agreement dated December 24, 2020 with a strategic investor, Ainos, Inc., a Cayman Islands corporation the Investor or Ainos KY focused on advanced technology diagnostic medical devices and artificial intelligence consumer healthcare solutions. Ainos KY develops and manufactures point-of-care testing POCT rapid test kit products that include diagnostics for COVID-19 SARS CoV2 Antigen Rapid Test, pneumonia, vaginal infection and helicobacter pylori H. 